Table 2 Distribution of HCV and parvovirus B19 among Afghanistan hemophilia patients(molecular-based assay results).
| Â | HCV Positive (8.75%) | HCV negative (91.25%) | P Value | CI (95%) | Parvovirus B19 Positive (43.75%) | Parvovirus B19 negative (56.25%) | P Value | CI (95%) |
|---|---|---|---|---|---|---|---|---|
Age 13.66 (±8.95) | <0.0001 | 0.003 to 0.177 |  | 0.741 | 0.435 to 1.686 | |||
   1–25 | 1 | 69 | 30 | 40 | ||||
   26–38 | 6 | 4 | 5 | 5 | ||||
Severity of hemophilia | 1.000 | 0.294 to 6.871 | Â | 0.246 | 0.801 to 2.522 | |||
   severe | 5 | 46 | 25 | 26 | ||||
   Mild and moderate | 2 | 27 | 10 | 19 | ||||
History of blood transfusion | 0.049 | 0.880 to 52.64 | Â | 0.504 | 0.499 to 1.375 | |||
   Yes | 6 | 32 | 15 | 23 | ||||
   No | 1 | 41 | 20 | 22 | ||||
